semaglutide and cardiovascular outcomes in obesity Association between 2.4 mg risk of events people with overweight or without atherosclerotic cardiovascular disease in the real-world: The SCORE – primary prevention study Semaglutide and Cardiovascular Health |

While it is too early to call an end to compounding, potential intervention by the FDA and DOJ could support the branded GLP-1 market, Flynn says

Prevention of Further Joint Damage Heres some great news: weight loss can actually slow down the progression of osteoarthritis

Dimpotriv, suplimentele cu L-carnitin (1000 mg i peste) sunt recomandate persoanelor care nu pot utiliza termogenice (arztoare de grsimi, de obicei cu stimulente precum cofeina) i celor cu probleme de tensiune arterial

Apoptosis, DNA damage, excitotoxicity, and oxidative stress may all play a role in developing hyperhomocysteinemia-induced neurodegenerative disorders (Cordaro et al

Carbonated beverages: The gas from carbonation has nowhere to go when your stomach empties slowly